Icodextrin increases natriuretic peptides in diabetic patients undergoing CAPD

Peritoneal Dialysis International

Volumn 26, Issue 5, 2006, Pages 604-607

  Bouchi, Ryotaro ^a   Babazono, Tetsuya ^a   Inoue, Aiko ^a   Tanaka, Mizuho ^a   Tanaka, Nobue ^a   Hase, Michiyo ^a   Ishii, Akiko ^a   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIANEAL; EXTRANEAL; GLUCOSE; HEMOGLOBIN A1C; ICODEXTRIN;

ADULT; AGED; AMPEROMETRY; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIALYSATE; DRUG BLOOD LEVEL; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LABORATORY TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSMOLALITY; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT DURATION; ULTRAFILTRATION; URINE VOLUME;

EID: 33750558931     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600517     Document Type: Article

References (12)

1. Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group. Perit Dial Int 2000; 20(Suppl 2):S106-13.
2. Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent K. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol 2001; 3:2:2.
3. Konings CJ, Kooman JP, Gladziwa U, van der Sande FM, Leunissen KM. A decline in residual glomerular filtration during the use of icodextrin may be due to under-hydration. Kidney Int 2005; 67:1190-1.
4. Burke RA, Hvizd MG, Shockley TR. Direct determination of polyglucose metabolites in plasma using anion-exchange chromatography with pulsed amperometric detection. J Chromatogr B Biomed Sci Appl 1997; 693:353-7.
5. Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, van den Wall Bake AW, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63:1556-63.
6. Davies SJ, Plum J, Woodrow G, Johansson AC, Williams P, Donovan K, et al. Increasing our understanding of the mechanism of action of icodextrin [Abstract]. Perit Dial Int 2004; 24(Suppl 2):S33.
7. Leunissen KM, Menheere PP, Cheriex EC, van den Berg BW, Noordzij TC, van Hooff JP. Plasma alpha-human atrial natriuretic peptide and volume status in chronic hemodialysis patients. Nephrol Dial Transplant 1989; 4:382-6.
8. Stein BC, Levin RI. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 1998; 135:914-23.
9. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-15.
10. Wilson PW. Diabetes mellitus and coronary heart disease. Am J Kidney Dis 1998; 32(Suppl 3):89-100.
11. Best PJ, Reddan DN, Berger PB, Szczech LA, McCullough PA, Califf RM. Cardiovascular disease and chronic kidney disease: insight and an update. Am Heart J 2004; 148: 230-42.
12. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.